ReviewFrontiers in ophthalmology2026
Ocular ischemic syndrome secondary to carotid artery disease: a comprehensive review addressing critical early detection, management, and education.
Review in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study was conducted to emphasize the significance of early detection of ocular ischemic syndrome (OIS), indicating advanced carotid atherosclerotic occlusive disease and preceding life-threatening ischemic cerebrovascular events, and to boost education in eyesight care. Methods: A systematic literature search was performed using PubMed and Embase databases using the keywords "carotid disease," "ocular ischemic syndrome," "amaurosis fugax," "early detection," and education, selecting 45 articles containing relevant information for our focused review. Results: OIS is a sight-threatening condition caused by ocular hypoperfusion, secondary to occlusive disease of the common or internal carotid arteries. We observed that this condition can be associated with multiple clinical manifestations, such as progressive or acute visual loss, orbital pain, and iris neovascularization. Carotid artery disease is frequently underdiagnosed due to an unfocused clinical examination of the eye fundus, the presence of carotid bruit, and other similarities associated with ocular ischemic syndrome, while the management of this condition should always be carried out with a multidisciplinary approach by implementing techniques such as panretinal photocoagulation (PRP), the use of ophthalmologic drugs, and surgical management of carotid via endarterectomy. Conclusions: Among clinicians, OIS is frequently undetected because the range of symptoms initially exhibited by an individual can mimic age-related visual decline, delaying detection until serious complications such as amaurosis fugax or stroke occur. Proficient skills in fundus examination and carotid artery auscultation are crucial in identifying this harmful condition, including the use of non-invasive procedures and full recognition of the need for early eye care education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.